| P50 | author | Xian Qin | Q96066577 |
| P2093 | author name string | Jianing Cao | |
| | Tianli Ren | |
| | Yuanxing Hang | |
| P2860 | cites work | 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative | Q56506042 |
| | High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors | Q77406810 |
| | Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors | Q81300622 |
| | Baicalin inhibits inflammation and attenuates myocardial ischaemic injury by aryl hydrocarbon receptor | Q86269574 |
| | Lipid-lowering therapy: who can benefit? | Q26827432 |
| | Biological properties of baicalein in cardiovascular system | Q28246946 |
| | Cardiac hypertrophy in aryl hydrocarbon receptor null mice is correlated with elevated angiotensin II, endothelin-1, and mean arterial blood pressure | Q28585378 |
| | Inflammation, atherosclerosis, and coronary artery disease | Q29547232 |
| | 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines | Q29620108 |
| | EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update | Q30244903 |
| | Therapeutic potentials of baicalin and its aglycone, baicalein against inflammatory disorders | Q30252979 |
| | Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis | Q33686973 |
| | Effects of Baicalin on Blood Pressure and Left Ventricular Remodeling in Rats with Renovascular Hypertension | Q33834911 |
| | Cardiovascular complications of rheumatoid arthritis: assessment, prevention, and treatment | Q33943374 |
| | Mortality in rheumatoid arthritis: 2008 update. | Q34014809 |
| | Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis | Q34283776 |
| | Atorvastatin causes insulin resistance and increases ambient glycemia in hypercholesterolemic patients | Q34467145 |
| | Coronary artery disease and rheumatoid arthritis | Q34531168 |
| | Antioxidative and anti-inflammatory activities of polyhydroxyflavonoids of Scutellaria baicalensis GEORGI. | Q34572786 |
| | Effects of statins on nonlipid serum markers associated with cardiovascular disease: a systematic review | Q35564135 |
| | Baicalin inhibits IL-17-mediated joint inflammation in murine adjuvant-induced arthritis | Q36959589 |
| | Integration of Chinese Herbal Medicine Therapy Improves Survival of Patients With Chronic Lymphocytic Leukemia: A Nationwide Population-Based Cohort Study | Q36992987 |
| | Bioactive components of Chinese herbal medicine enhance endogenous neurogenesis in animal models of ischemic stroke: A systematic analysis | Q37328823 |
| | Apolipoprotein B levels, APOB alleles, and risk of ischemic cardiovascular disease in the general population, a review | Q37387849 |
| | Cardiovascular risk and rheumatoid arthritis--the next step: differentiating true soluble biomarkers of cardiovascular risk from surrogate measures of inflammation | Q37900782 |
| | Atherosclerosis in rheumatoid arthritis: is it all about inflammation? | Q38396964 |
| | Baicalin Attenuates Cardiac Dysfunction and Myocardial Remodeling in a Chronic Pressure-Overload Mice Model | Q38715838 |
| | Cardiorespiratory fitness levels and their association with cardiovascular profile in patients with rheumatoid arthritis: a cross-sectional study | Q38981341 |
| | New insights to the mechanisms underlying atherosclerosis in rheumatoid arthritis. | Q39138216 |
| | Evaluation of antioxidant and inhibitory activities for different subclasses flavonoids on enzymes for rheumatoid arthritis | Q39550007 |
| | A Role for the Aryl Hydrocarbon Receptor in Cardiac Physiology and Function as Demonstrated by AhR Knockout Mice | Q44591056 |
| | Risk assessment for coronary heart disease in rheumatoid arthritis and osteoarthritis | Q45129671 |
| | Inhibitory effect of baicalin on collagen-induced arthritis in rats through the nuclear factor-κB pathway | Q46716986 |
| | Aryl hydrocarbon receptor null mice develop cardiac hypertrophy and increased hypoxia-inducible factor-1alpha in the absence of cardiac hypoxia | Q48004230 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P921 | main subject | coronary artery disease | Q844935 |
| | rheumatoid arthritis | Q187255 |
| | placebo | Q269829 |
| | baicalin | Q2879368 |
| P304 | page(s) | 146 | |
| P577 | publication date | 2018-06-23 | |
| P1433 | published in | Lipids in Health and Disease | Q15756695 |
| P1476 | title | Baicalin reduces blood lipids and inflammation in patients with coronary artery disease and rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial. | |
| P478 | volume | 17 | |